Article
Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study.
International journal of cancer - 15 Jul 2014
Dik Vincent K, Bueno-de-Mesquita H B As, Van Oijen Martijn G H, Siersema Peter D, Uiterwaal Cuno S P M, Van Gils Carla H, Van Duijnhoven Fränzel J B, Cauchi Stéphane, Yengo Loic, Froguel Philippe, Overvad Kim, Bech Bodil H, Tjønneland Anne, Olsen Anja, Boutron-Ruault Marie-Christine, Racine Antoine, Fagherazzi Guy, Kühn Tilman, Campa Daniele, Boeing Heiner, Aleksandrova Krasimira, Trichopoulou Antonia, Peppa Eleni, Oikonomou Eleni, Palli Domenico, Grioni Sara, Vineis Paolo, Tumino Rosaria, Panico Salvatore, Peeters Petra H M, Weiderpass Elisabete, Engeset Dagrun, Braaten Tonje, Dorronsoro Miren, Chirlaque María-Dolores, Sánchez María-José, Barricarte Aurelio, Zamora-Ros Raul, Argüelles Marcial, Jirström Karin, Wallström Peter, Nilsson Lena M, Ljuslinder Ingrid, Travis Ruth C, Khaw Kay-Tee, Wareham Nick, Freisling Heinz, Licaj Idlir, Jenab Mazda, Gunter Marc J, Murphy Neil, Romaguera-Bosch Dora, Riboli Elio
Abstract excerpt
Coffee and tea contain numerous antimutagenic and antioxidant components and high levels of caffeine that may protect against colorectal cancer (CRC). We investigated the association between coffee and tea consumption and CRC risk and studied potential effect modification by CYP1A2 and NAT2 genotypes, enzymes involved in the metabolization of caffeine. Data from 477,071 participants (70.2% female) of the European...
Read the complete abstract on PubMed